← The Wire
ALXONasdaq
ALX ONCOLOGY HOLDINGS INC
Pharmaceutical Preparations · DE · CIK 1810182
Develops immuno-oncology treatments, like evorpacept, to help patients fight cancer by blocking CD47 signals
red 8-K · 90d
$213M
Market cap
$2.20
Last close
+7.8%
1D
+35.0%
5D
2.2M
Volume
Price · last 39 sessions+17.0%
May 4L $1.38 · H $2.20Jun 29
113
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Agreement TerminatedJun 26, 20268-KShareholder VoteJun 11, 2026SC 13D/ASC 13D/AMay 27, 202610-Q10-QMay 8, 20268-KResults of OperationsMay 8, 2026DEF 14ADEF 14AApr 20, 20268-KExecutive Change · Reg FD DisclosureApr 13, 202610-K10-KMar 9, 20268-KResults of OperationsFeb 27, 2026SC 13D/ASC 13D/AFeb 4, 2026424B5424B5Jan 30, 20268-KMaterial Agreement · Company UpdateJan 30, 20268-KCompany UpdateJan 30, 20268-KExecutive ChangeJan 21, 202610-Q10-QNov 7, 20258-KResults of OperationsNov 7, 20258-KExecutive Change · Company UpdateSep 12, 202510-Q10-QAug 12, 20258-KExecutive Change · Results of OperationsAug 12, 20258-KShareholder VoteJun 12, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KDelisting NoticeApr 25, 2025DEF 14ADEF 14AApr 21, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 20258-KExecutive Change · Exit / Disposal CostsMar 5, 20258-KExecutive Change · Reg FD DisclosureJan 22, 20258-KExecutive ChangeJan 17, 20258-KExecutive Change · Reg FD DisclosureNov 14, 202410-Q10-QNov 7, 20248-KExecutive Change · Results of OperationsNov 7, 20248-KExecutive ChangeOct 4, 2024SC 13GSC 13GAug 22, 2024SC 13GSC 13GAug 13, 202410-Q10-QAug 12, 20248-KResults of OperationsAug 8, 20248-KExecutive Change · Company UpdateAug 6, 20248-KShareholder VoteJun 17, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AMay 2, 20248-KExecutive ChangeMay 2, 2024DEF 14ADEF 14AApr 22, 202410-K10-KMar 7, 20248-KResults of OperationsMar 7, 20248-KMaterial Agreement · New Debt / ObligationDec 26, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 2023SC 13GSC 13GOct 16, 2023SC 13GSC 13GOct 13, 20238-KMaterial Agreement · Company UpdateOct 6, 2023424B5424B5Oct 6, 20238-KResults of OperationsOct 4, 2023424B5424B5Oct 4, 20238-KCompany UpdateOct 4, 20238-KExecutive Change · Reg FD DisclosureSep 6, 2023424B5424B5Aug 25, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KBylaw Amendment · Shareholder VoteJun 20, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEF 14ADEF 14AApr 24, 20238-KReg FD DisclosureMar 13, 202310-K10-KMar 9, 20238-KResults of OperationsMar 9, 2023SC 13GSCHEDULE 13GFeb 14, 20238-KExecutive ChangeNov 29, 202210-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KMaterial Agreement · New Debt / ObligationOct 31, 202210-Q10-QAug 8, 20228-KResults of OperationsAug 8, 20228-KShareholder VoteJun 16, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 2022DEF 14ADEF 14AApr 22, 20228-KExecutive ChangeApr 12, 202210-K10-KFeb 28, 2022
Insider Activity
In the 90 days to Mar 19, 2026: 1 insider bought $5.0M · 2 sold $34K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Lettmann JasonCHIEF EXECUTIVE OFFICER | Sell | 12,311 | $2.17 | $27K |
| Mar 19, 2026 | Pinto ShellySVP, FINANCE AND CAO | Sell | 903 | $2.17 | $2K |
| Feb 18, 2026 | Pinto ShellySVP, FINANCE AND CAO | Sell | 565 | $2.27 | $1K |
| Feb 2, 2026 | Goodman Corey SDirector,TenPercentOwner | Buy | 3,184,713 | $1.57 | $5.0M |
| Jan 6, 2026 | Pinto ShellySVP, FINANCE AND CAO | Sell | 3,925 | $1.11 | $4K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance